BioPlus Acquisition Corp.

NASDAQ: BIOS · Real-Time Price · USD
10.79
-0.01 (-0.09%)
At close: Oct 06, 2023, 9:46 PM

BioPlus Acquisition Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
140.3K 635.54K
Short-Term Investments
237.78M n/a
Long-Term Investments
237.78M n/a
Other Long-Term Assets
n/a 234.98M
Receivables
n/a n/a
Inventory
n/a n/a
Other Current Assets
408.46K 366.74K
Total Current Assets
548.76K 1M
Property-Plant & Equipment
n/a n/a
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
237.78M 234.98M
Total Assets
238.32M 235.98M
Account Payables
n/a n/a
Deferred Revenue
408.46K n/a
Short-Term Debt
n/a n/a
Other Current Liabilities
526.88K 179.14K
Total Current Liabilities
526.88K 179.14K
Long-Term Debt
5M 5M
Other Long-Term Liabilities
9.8M 9.8M
Total Long-Term Liabilities
14.8M 14.8M
Total Liabilities
15.33M 14.98M
Total Debt
5M 5M
Common Stock
237.78M 234.6M
Retained Earnings
-14.78M -13.6M
Comprehensive Income
n/a n/a
Shareholders Equity
223M 221M
Total Investments
237.78M n/a